From Present to Future

Technological advances clearly drive innovation in the pharmaceutical and health-care industries. Advances in the speed and accuracy of DNA sequencing and the growing understanding of the genome have created hundreds of companies, with billions of dollars in assets, that are using this information to contribute to the creation of new diagnostic and therapeutic agents. This has been accomplished even before science has achieved full knowledge of the human DNA sequence or a complete understanding of the function of most human genes. It is expected that the next decade will provide the remaining human genomic information, which will enable a breathtaking array of new therapeutic and preventive options for the treatment of human disease. see also Bioinformatics; Biotechnology; Combinatorial Chemistry; Genome; High-throughput Screening; Human Genome Project; Pharmacogenetics and Pharmacogenomics.

Kenneth W. Culver and Mark A. Labow

Bibliography

Internet Resource

Genomic Industry Web Guide. <http://www.business2business.com/webguide/ o,1660,49834,ff.html>.

OOOCX

antibodies immune system proteins that bind to foreign molecules

0 0

Post a comment